Yuan Shen

Dr. Yuan Shen


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2011 in International Journal of Radiation Biology
Verified
Journal Article
Open access
PDF file
LBLotte B. Bertelsen
Lotte B. Bertelsen
YSYuan Shen
Yuan Shen
TNThomas Nielsen
Thomas Nielsen
HSHans Stødkilde-Jørgensen
Hans Stødkilde-Jørgensen
GLG. Kenneth Lloyd
G. Kenneth Lloyd
MHMichael Robert Horsman
Michael Robert Horsman
Purpose: This study investigated the anti-tumour effects of the novel vascular disrupting agent plinabulin (NPI-2358) when given alone or combined with radiation. Materials and methods: Foot implanted C3H mammary carcinomas or leg implanted KHT sarcomas were used, with plinabulin injected intraperitoneally. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) measurements were made with gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) on a 7-tesla magnet. Treatment response was assessed using regrowth delay (C3H tumours), clonogenic survival (KHT sarcomas) or histological estimates of necrosis for both models. Results: Plinabulin (7.5 mg/kg) significantly reduced the initial area under curve (IAUC) and the transfer constant (Ktrans) within 1 hour after injection, reaching a nadir at 3 h, but returning to normal within 24 h. A dose-dependent decrease in IAUC and Ktrans, was seen at 3 h. No significant anti-tumour effects were observed in the C3H tumours until doses of 12.5 mg/kg were achieved, but started at 1.5 mg/kg in the KHT sarcoma. Irradiating tumours 1 h after injecting plinabulin enhanced response in both models. Conclusions: Plinabulin induced a time- and dose-dependent decrease in tumour perfusion. The KHT sarcoma was more sensitive than the C3H tumour to the anti-tumour effects of plinabulin, while radiation response was enhanced in both models.

27 October 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
LGLinzhi Gao
Linzhi Gao
JLJun Lyu
Jun Lyu
XLXiaoya Luo
Xiaoya Luo
DZDong Zhang
Dong Zhang
GJGuifang Jiang
Guifang Jiang
YSYuan Shen
Yuan Shen
Purpose: Aims to compare the prognostic performance of the number of positive lymph nodes (PLNN), lymph node ratio (LNR) and log odds of metastatic lymph nodes (LODDS) and establish a prognostic nomogram to predict overall survival (OS) rate for patients with endometrial carcinosarcoma (ECS). Methods: Patients were retrospectively obtained from Surveillance, Epidemiology and End Results (SEER) database from 2004 to 2015. The prognostic value of PLNN, LNR and LODDS were assessed. A prediction model for OS was established based on univariate and multivariate analysis of clinical and demographic characteristics of ECS patients. The clinical practical usefulness of the prediction model was valued by decision curve analysis (DCA) through quantifying its net benefits. Results: The OS prediction accuracy of LODDS for ECS is better than that of PLNN and LNR. Five factors, age, tumor size, 2009 FIGO, LODDS and peritoneal cytology, were independent prognostic factors of OS. The C-index of the nomogram was 0.743 in the training cohort. The AUCs were 0.740, 0.682 and 0.660 for predicting 1-, 3- and 5-year OS, respectively. The calibration plots and DCA showed good clinical applicability of the nomogram, which is better than 2009 FIGO staging system. These results were verified in the validation cohort. A risk classification system was built that could classify ECS patients into three risk groups. The Kaplan-Meier curves showed that OS in the different groups was accurately differentiated by the risk classification system and performed much better than FIGO 2009. Conclusion: Our results indicated that LODDS was an independent prognostic indicator for ECS patients, with better predictive efficiency than PLNN and LNR. A novel prognostic nomogram for predicting the OS rate of ECS patients was established based on the population in the SEER database. Our nomogram based on LODDS has a more accurate and convenient value for predicting the OS of ECS patients than the FIGO staging system alone.

25 February 2025 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
LGLinzhi Gao
Linzhi Gao
GJGuifang Jiang
Guifang Jiang
ELEnming Liang
Enming Liang
YZYing Zhang
Ying Zhang
BCBaoling Cheng
Baoling Cheng
YSYuan Shen
Yuan Shen
Linzhi Gao, Guifang Jiang, Enming Liang, Ying Zhang, Baoling Cheng, Xian Zhang, Dong Zhang, Xiaoyu Wang, Yuan Shen. IJSC -0001;0:. https://doi.org/10.15283/ijsc24079

10 July 2025 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
YLYunqi Liu
Yunqi Liu
DZDong Zhang
Dong Zhang
LGLinzhi Gao
Linzhi Gao
SZSiqi Zhou
Siqi Zhou
YSYuan Shen
Yuan Shen

27 June 2023 in Genomics
Verified
Journal Article
Open access
LGLinzhi Gao
Linzhi Gao
ELEnming Liang
Enming Liang
DZDong Zhang
Dong Zhang
YZYing Zhang
Ying Zhang
XZXian Zhang
Xian Zhang
YSYuan Shen
Yuan Shen
Although intrauterine adhesion (IUA) has been well recognized as a critical factor in infertility, little information is available regarding the molecular mechanisms. We performed a high-throughput RNA sequencing in the endometrium of three IUA patients and three normal controls. And another two gene expression profiles (PMID34968168 and GSE160365) were analyzed together. A total of 252 DEGs were identified. Cell cycle, E2F target, G2M checkpoint, integrin3 pathway and H1F1 signaling were aberrantly regulated in the IUA endometrium. 10 hub genes (CCL2, TFRC, THY1, IGF1, CTGF, SELL, SERPINE1, HBB, HBA1, LYZ) were exhibited in PPI analysis. FOXM1, IKBKB and MYC were three common transcription factors of DEGs. Five chemicals (MK-1775, PAC-1, TW-37, BIX-01294, 3-matida) were identified as putative therapeutic agents for IUA. Collectively, a series of DEGs associated with IUA were disclosed. Five chemicals and ten hub genes may be further explored as potential drugs and targets for IUA treatment.

10 July 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
RLRen Li
Ren Li
JXJinquan Xia
Jinquan Xia
CZChang Zou
Chang Zou
YXYixia Xie
Yixia Xie
YSYuan Shen
Yuan Shen
Aims and objectives: High-grade serous ovarian cancer (HGSOC) ascites represents a highly immunosuppressive tumour microenvironment characterized by complex stromal–immune interactions. In this study, we aimed to delineate the cellular communication networks shaping immune dysfunction within HGSOC ascites, identify key regulatory signalling pathways, characterize the fibroblast–macrophage axis at single-cell resolution, and evaluate the therapeutic potential of IL-10 blockade in reversing macrophage-mediated immunosuppression. Methods: Single-cell RNA sequencing data of eight ascites samples from six HGSOC patients (GSE146026) were analysed using Seurat for clustering and differential expression, followed by CellChat to infer ligand–receptor communication. Sub-clustering defined inflammatory CAFs (iCAF), myofibroblast CAFs (mCAF), and macrophage subtypes (M1/M2). GO/KEGG enrichment assessed functional pathways. Multiplex immunofluorescence validated spatial interactions of IL10+ iCAF and IL10RA+ macrophages in patient tissues. An immune-humanized patient-derived xenograft (PDX) mouse model was established to evaluate the therapeutic effect of IL-10 blockade. Results: Single-cell transcriptomic analysis of HGSOC ascites revealed macrophages and cancer-associated fibroblasts as dominant cell populations within the tumour microenvironment. Cell–cell communication analysis identified IL-10–IL-10RA signalling as a prominent interaction pathway linking inflammatory CAFs (iCAFs) with M2-like macrophages. iCAFs displayed elevated IL-10 expression, while M2 macrophages showed increased IL-10RA/IL-10RB expression and were associated with exhausted immune states. Multiplex immunofluorescence confirmed spatial proximity between IL-10 + iCAFs and IL-10RA + M2 macrophages in tumour tissues. In immune-humanized PDX models, IL-10 blockade with MK-1966 significantly suppressed tumour growth and reduced expression of M2 macrophage markers and proliferation-associated proteins. Conclusion: This study identifies an IL-10-dependent iCAF–M2 macrophage immunoregulatory circuit as a central mechanism driving immune suppression in HGSOC. Targeting the IL-10 pathway effectively reverses M2 polarization and suppresses tumour progression, highlighting IL-10 blockade as a promising therapeutic strategy in ovarian cancer.